BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang L, Fang X, Bao Y, Zhou JY, Shen XY, Ding MH, Chen Y, Hu GH, Lu YC. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies. PLoS One 2013;8:e55597. [PMID: 23383237 DOI: 10.1371/journal.pone.0055597] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Liu Z, Zhang W, Cheng X, Wang H, Bian L, Wang J, Han Z, Wang Y, Lian X, Liu B, Ren Z, Zhang B, Jiang Z, Lin Z, Gao Y. Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients. Mol Med 2021;27:52. [PMID: 34051735 DOI: 10.1186/s10020-021-00316-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
2 Qian X, Tan H, Zhang J, Liu K, Yang T, Wang M, Debinskie W, Zhao W, Chan MD, Zhou X. Identification of biomarkers for pseudo and true progression of GBM based on radiogenomics study. Oncotarget. 2016;7:55377-55394. [PMID: 27421136 DOI: 10.18632/oncotarget.10553] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
3 Tamimi AF, Juweid M; Department of Neurosurgery, Jordan University Hospital and Medical School, University of Jordan, Amman, Jordan, Department of Radiology and Nuclear Medicine, Jordan University Hospital and Medical School, University of Jordan, Amman, Jordan. Epidemiology and Outcome of Glioblastoma. In: De Vleeschouwer S, editor. Glioblastoma. Codon Publications; 2017. pp. 143-53. [DOI: 10.15586/codon.glioblastoma.2017.ch8] [Cited by in Crossref: 143] [Cited by in F6Publishing: 149] [Article Influence: 23.8] [Reference Citation Analysis]
4 Lu JT, Deng AP, Song J, Zhang L, Luo J. Reappraisal of XRCC1 Arg194Trp polymorphism and glioma risk: a cumulative meta-analysis. Oncotarget 2017;8:21599-608. [PMID: 28423490 DOI: 10.18632/oncotarget.15376] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Shamran HA, Ghazi HF, Al-Salman A, Al-Juboory AA, Taub DD, Price RL, Nagarkatti M, Nagarkatti PS, Singh UP. Single Nucleotide Polymorphisms in IL-10, IL-12p40, and IL-13 Genes and Susceptibility to Glioma. Int J Med Sci 2015;12:790-6. [PMID: 26516307 DOI: 10.7150/ijms.12609] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
6 Feng X, Miao G, Han Y, Xu Y, Wu H. Glioma risks associate with genetic polymorphisms of XRCC1 gene in Chinese population. J Cell Biochem 2014;115:1122-7. [PMID: 24375631 DOI: 10.1002/jcb.24753] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
7 He LW, Shi R, Jiang L, Zeng Y, Ma WL, Zhou JY. XRCC1 gene polymorphisms and glioma risk in Chinese population: a meta-analysis. PLoS One 2014;9:e111981. [PMID: 25375625 DOI: 10.1371/journal.pone.0111981] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
8 Li J, Qu Q, Qu J, Luo WM, Wang SY, He YZ, Luo QS, Xu YX, Wang YF. Association between XRCC1 polymorphisms and glioma risk among Chinese population. Med Oncol 2014;31:186. [PMID: 25245010 DOI: 10.1007/s12032-014-0186-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
9 Feng YZ, Liu YL, He XF, Wei W, Shen XL, Xie DL. Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies. Tumour Biol 2014;35:10677-97. [PMID: 25064613 DOI: 10.1007/s13277-014-2326-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
10 Gao X, Mi Y, Yan A, Sha B, Guo N, Hu Z, Zhang N, Jiang F, Gou X. The PHLDB1 rs498872 (11q23.3) polymorphism and glioma risk: A meta-analysis. Asia Pac J Clin Oncol 2015;11:e13-21. [PMID: 24935770 DOI: 10.1111/ajco.12211] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
11 Zhou JY, Shi R, Jiang L, Zeng Y, Ma WL. Letter regarding Zhu et al. entitled "Assessment of the association between XRCC1 Arg399Gln polymorphism and glioma susceptibility". Tumour Biol 2014;35:6181-2. [PMID: 24715306 DOI: 10.1007/s13277-014-1931-z] [Reference Citation Analysis]
12 Anand R, Prakash SS, Veeramanikandan R, Kirubakaran R. Association between apolipoprotein E genotype and cancer susceptibility: a meta-analysis. J Cancer Res Clin Oncol 2014;140:1075-85. [PMID: 24706182 DOI: 10.1007/s00432-014-1634-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
13 Mehrzad J, Monajjemi M, Hashemi M. In silico study of effects of polymorphisms on biophysical chemical properties of oxidized N-terminal domain of X-ray cross-complementing group 1 protein. Biochemistry (Mosc) 2014;79:31-6. [PMID: 24512661 DOI: 10.1134/S0006297914010052] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Adel Fahmideh M, Schwartzbaum J, Frumento P, Feychting M. Association between DNA repair gene polymorphisms and risk of glioma: a systematic review and meta-analysis. Neuro Oncol 2014;16:807-14. [PMID: 24500421 DOI: 10.1093/neuonc/nou003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
15 Yuan G, Gao D, Ding S, Tan J. DNA repair gene ERCC1 polymorphisms may contribute to the risk of glioma. Tumour Biol 2014;35:4267-75. [PMID: 24453030 DOI: 10.1007/s13277-013-1557-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
16 Rodriguez-Hernandez I, Perdomo S, Santos-Briz A, Garcia JL, Gomez-Moreta JA, Cruz JJ, Gonzalez-Sarmiento R. Analysis of DNA repair gene polymorphisms in glioblastoma. Gene 2014;536:79-83. [PMID: 24325908 DOI: 10.1016/j.gene.2013.11.077] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
17 Zhu W, Yao J, Li Y, Xu B. Assessment of the association between XRCC1 Arg399Gln polymorphism and glioma susceptibility. Tumour Biol 2014;35:3061-6. [PMID: 24258108 DOI: 10.1007/s13277-013-1397-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
18 Wang Y, Chu X, Meng X, Zou F. Association of X-ray repair cross complementing group 1 Arg399Gln polymorphisms with the risk of squamous cell carcinoma of the head and neck: evidence from an updated meta-analysis. PLoS One 2013;8:e77898. [PMID: 24205020 DOI: 10.1371/journal.pone.0077898] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
19 Xu G, Wang M, Xie W, Bai X. Three polymorphisms of DNA repair gene XRCC1 and the risk of glioma: a case–control study in northwest China. Tumor Biol 2014;35:1389-95. [DOI: 10.1007/s13277-013-1191-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
20 Jin Z, Xu H, Zhang X, Zhao G. Genetic polymorphisms in XRCC1 gene and susceptibility to glioma in Chinese Han population. Tumour Biol 2014;35:357-62. [PMID: 23918303 DOI: 10.1007/s13277-013-1050-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Xu C, Yuan L, Tian H, Cao H, Chen S. Association of the MTHFR C677T polymorphism with primary brain tumor risk. Tumour Biol 2013;34:3457-64. [PMID: 23846816 DOI: 10.1007/s13277-013-0922-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
22 Lu Q, Dai D, Zhao W, Wang L, Yue Z, Chen X, Han G, Hao B, Yang P, Deng A, Liu J. Association between MTHFR 677C>T polymorphism and risk of gliomas: evidence from a meta-analysis. Tumour Biol 2013;34:2801-7. [PMID: 23765760 DOI: 10.1007/s13277-013-0838-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]